This webinar 'In conversation with... James Allison' from the National Cancer Research Institute is supported by the British Society for Immunology. In 2019 the BSI established a partnership with the NCRI to bring the immunology and cancer communities together to drive collaborations that address current challenges in immunotherapy through a series of joint initiatives, including this webinar.
This virtual event will take place Monday 21 June, 15:00 - 15:45 BST.
This session, jointly chaired by Professor Rob Bristow from the University of Manchester and Dr Sophie Papa from King’s College London, will focus on the distinguished career of American immunologist, Dr James Allison who earned a Nobel Prize in 2018 for his pioneering research in cancer therapy. Dr Allison from The University of Texas MD Anderson Cancer Center (USA), will share how this particular immunology research (amongst many of his other achievements) revolutionised cancer treatment when he discovered how to free the immune system to attack tumours. The conversation will also explore his current work that seeks to improve immune checkpoint blockade therapies and identify new targets to unleash the immune system in order to eradicate cancer, and cover Dr Allison’s interest in immune responses in cancer patients treated with immunotherapy.
Scientists, clinicians, immunologists and other allied health professionals working in this area of research, as well as patient experts, are welcomed to attend. Find out more and register here.
Speaker: Dr James Allison, The University of Texas MD Anderson Cancer Center, USA
Chairs: Professor Rob Bristow, University of Manchester, UK and Dr Sophie Papa, King’s College London, UK